CSPC Pharmaceutical Group(HK:1093)
HK$8.30+0.32 (+3.94%)
HK:1093
CSPC Pharmaceutical Group financials statements
HK$8.30
At close:+0.32 (+3.94%)
Want to see HK:1093 full AI Analyst Report?
CSPC Pharmaceutical Group (1093) Income Statement
35 Followers
CSPC Pharmaceutical Group Income Statement
Last quarter (Q2 2026), CSPC Pharmaceutical Group's total revenue was HK$18.34B, an increase of 11.72% from the same quarter last year. In Q2, CSPC Pharmaceutical Group's net income was HK$6.01B. See CSPC Pharmaceutical Group’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| HK$ 25.33B | HK$ 29.54B | HK$ 31.47B | HK$ 31.59B | HK$ 27.41B | |
| HK$ 16.62B | HK$ 20.67B | HK$ 22.19B | HK$ 22.73B | HK$ 20.79B | |
| HK$ 12.75B | HK$ 15.22B | HK$ 15.19B | HK$ 15.80B | HK$ 14.64B | |
| Depreciation and Amortization | HK$ 1.37B | HK$ 1.34B | HK$ 1.12B | HK$ 1.05B | HK$ 865.47M |
| HK$ 5.24B | HK$ 7.16B | HK$ 8.59B | HK$ 8.83B | HK$ 7.58B | |
| HK$ 3.87B | HK$ 5.45B | HK$ 7.01B | HK$ 6.93B | HK$ 6.14B | |
| HK$ 815.45M | HK$ 229.71M | HK$ 388.72M | HK$ 811.55M | HK$ 591.96M | |
| HK$ 4.68B | HK$ 5.68B | HK$ 7.39B | HK$ 7.74B | HK$ 6.73B | |
| HK$ 3.78B | HK$ 4.41B | HK$ 5.88B | HK$ 6.22B | HK$ 5.51B | |
| Per Share Metrics | |||||
| Basic EPS | HK$ 0.33 | HK$ 0.38 | HK$ 0.50 | HK$ 0.52 | HK$ 0.46 |
| Diluted EPS | HK$ 0.33 | HK$ 0.38 | HK$ 0.49 | HK$ 0.52 | HK$ 0.46 |
| Weighted Average Shares Outstanding | 11.42B | 11.74B | 11.87B | 11.92B | 11.95B |
| Weighted Average Shares Outstanding (Diluted) | 11.42B | 11.74B | 11.87B | 11.92B | 11.95B |
Currency in HKD

